September 03, 2026

Hamamatsu Receives FDA 510(k) Clearance for NanoZoomer S20MD and S540MD Slide scanner systems

Hamamatsu: New FDA clearances expand Hamamatsu's FDA-cleared NanoZoomer portfolio with compact benchtop and high-throughput digital pathology solutions. HAMAMATSU, Japan, Sept. 2, 2026 /PRNewswire/ -- Hamamatsu Photonics K.K. today announced that it has received...

recent articles

Join Aiforia for their latest webinar! Developing an AI tool for renal pathology: case Galileo Monday, December 16 10:00-11:00 a.m. EST / 4:00-5:00 p.m. CET Register Now Summary Join this webinar to discover how artificial...

Experience the opportunity to make a significant impact in oncology care and research. Fox Chase Cancer Center, part of Temple University Health System, seeks a BC/BE Surgical Pathologist to join its stable, collegial team in Philadelphia. As...

DEA addressed the status of telemedicine prescribing flexibilities including state reciprocity (DEA-DC-018 EO-DEA067) and medications for opioid use disorder prescribed by telephone (DEA-DC-022 EO-DEA068) in the temporary rule titled "Temporary...

Philips: Cloud-enabled integrated diagnostics portfolio aims to unify workflows, improve access to critical insights, and drive better outcomes for patients Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global...

Mount Sinai: New state-of-the-art facility is among the first of its kind at a U.S. medical school New York, NY, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Today, the Mount Sinai Health System, one of New York City’s largest academic medical systems,...

PreciseDX: World-Renowned Breast Cancer Oncology and Pathology Experts to Advise Company on the Advancement of its AI-Powered PreciseBreastTM Risk of Recurrence Assessment and Product Portfolio NEW YORK, Nov. 20, 2024 /PRNewswire/...

OR

platinum partners

gold partners

Silver Partners

Media Partners